Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
6.88
-0.11 (-1.57%)
At close: Jul 29, 2026, 4:00 PM EDT
6.98
+0.10 (1.44%)
After-hours: Jul 29, 2026, 7:34 PM EDT
Rockwell Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Rockwell Medical stock has a consensus rating of "Buy" and an average price target of $30. The average 1-year stock price forecast is 336.05% higher than the current stock price, while the lowest is $20 (+190.70%) and the highest is $40 (+481.40%).
Price Target: $30 (+336.05%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rockwell Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Nov '25 | Jan '26 | Mar '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +190.70% | Jul 9, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $40 | Buy | Maintains | $40 | +481.40% | May 8, 2026 |
Financial Forecast
Revenue This Year
72.47M
from 69.26M
Increased by 4.64%
Revenue Next Year
78.29M
from 72.47M
Increased by 8.03%
EPS This Year
61.60
EPS Next Year
72.60
from 61.60
Increased by 17.86%
EPS and Forward PE are based on non-GAAP adjusted numbers.